Quantum Blue®Anti-Infliximab and Anti-Adalimumab Tests Now Available

New Quantum Blue® TDM Assays

BÜHLMANN is proud to introduce Quantum Blue® Anti-Infliximab (RUO) and Anti-Adalimumab (RUO) to the TDM rapid test portfolio.  These new assays together with the infliximab and adalimumab trough level rapid tests offer the complete package for infliximab and adalimumab TDM testing on the popular Quantum Blue® platform.

BÜHLMANN Quantum Blue® Anti-Infliximab and Quantum Blue® Anti-Adalimumab are for Research Use Only in the US. Not for use in diagnostics procedures in the US.

Quantum Blue® Anti-Infliximab

Assay information:

Rapid and Quantitative Lateral Flow Assay for Anti-Infliximab

Quantum Blue® Anti-Infliximab is for Research Use Only in the US.  Not for use in diagnostic procedures.

Quantum Blue® Anti-Infliximab Poster Presentation at ECCO 2019

Learn more about this Quantum Blue® Anti-Infliximab lateral flow assay assay in a recent poster citation.

Quantum Blue® Anti-Adalimumab

Assay information:

Rapid and Quantitative Lateral Flow Assay for Anti-Adalimumab

Quantum Blue® Anti-Adalimumab is for Research Use Only in the US.  Not for use in diagnostic procedures.

Quantum Blue® Anti-Adalimumab Poster at ECCO 2019

Learn more about this Quantum Blue® Anti-Adalimumab lateral flow assay assay in a recent poster citation.